Reuters logo
BRIEF-Incyte says epacadostat, Bristol-Myers' Opdivo combo data positive in head and neck cancer patients
June 5, 2017 / 11:47 AM / 6 months ago

BRIEF-Incyte says epacadostat, Bristol-Myers' Opdivo combo data positive in head and neck cancer patients

June 5 (Reuters) - Incyte Corp

* Clinical trial data for combination of epacadostat and opdivo® (nivolumab) demonstrate durable clinical responses in patients with melanoma and head and neck cancer

* Incyte corp - combination of ido1 enzyme inhibition plus opdivo was generally well-tolerated in patients with select advanced solid tumors Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below